美国胃肠内镜学会指南:内镜在实体胰腺肿块诊断与管理中的作用:摘要与推荐
美国胃肠内镜学会(ASGE)基于GRADE框架制定本指南,针对实体胰腺肿块的内镜诊治提出推荐:EUS-TA推荐FNB针而非FNA针,建议22G而非25G针,推荐叉尖或Franseen型FNB针,建议不常规使用ROSE;ERCP胆道引流建议SEMS而非塑料支架,建议覆膜SEMS而非裸SEMS,未病理确诊恶性肿瘤推荐不用裸SEMS;不可切除胰腺癌腹痛建议CPN辅助镇痛。
要点
- EUS-TA推荐FNB针而非FNA针,建议22G而非25G针。
- 使用FNB针时推荐叉尖或Franseen针而非其他设计。
- 初次EUS-TA不建议常规使用ROSE。
核心结论
- ASGE基于GRADE框架对实体胰腺肿块内镜诊治提出推荐,涵盖针具选择、标本处理、支架选择及疼痛管理。
研究设计与样本
- 美国胃肠内镜学会(ASGE)临床实践指南,采用推荐分级的评估、制定与评价(GRADE)框架制定。
主要发现
- 指南针对实体胰腺肿块EUS-TA的针具选择(FNB vs FNA)、针径(22G vs 25G)、FNB针类型(新型或当代叉尖与Franseen vs 其他FNB设计)及标本处理(ROSE vs 无ROSE)提出推荐。
- 指南针对远端恶性胆道梗阻ERCP引流的支架选择(SEMS vs 塑料支架)、SEMS类型(覆膜 vs 裸SEMS)及疼痛管理(CPN vs 药物镇痛)提出推荐。
- 文件概述了达成最终推荐的过程、分析与决策方法,代表ASGE在上述主题的官方推荐。
关键数值与推荐
- 实体胰腺肿块行EUS-TA者,ASGE推荐FNB针而非FNA针。
- 针径方面,ASGE建议22G而非25G针。
- 使用FNB针时,ASGE推荐叉尖或Franseen针而非其他FNB针设计。
- 初次EUS-TA实体胰腺肿块获得标本后,ASGE建议不常规使用ROSE。
- 远端恶性胆道梗阻行ERCP引流者,ASGE建议SEMS而非塑料支架。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This clinical practice guideline from the American Society for Gastrointestinal Endoscopy (ASGE) provides an evidence-based approach for the role of endoscopy in the diagnosis and management of pancreatic masses. This document was developed using the Grading of Recommendations Assessment, Development and Evaluation framework and addresses needle selection (fine-needle biopsy [FNB] needle vs FNA needle), needle caliber (22-gauge vs 25-gauge needles), FNB needle type (novel or contemporary [fork-tip and Franseen] vs alternative FNB needle designs), and sample processing (rapid on-site evaluation [ROSE] vs no ROSE). In addition, this guideline addresses stent selection (self-expandable metal stents [SEMS] vs plastic stents), SEMS type (covered [cSEMS] vs uncovered [uSEMS]), and pain management (celiac plexus neurolysis [CPN] vs medical analgesic therapy). In patients with solid pancreatic masses undergoing EUS-guided tissue acquisition (EUS-TA), the ASGE recommends FNB needles over FNA needles. With regard to needle caliber, the ASGE suggests 22-gauge over 25-gauge needles. When an FNB needle is used, the ASGE recommends using either a fork-tip or a Franseen needle over alternative FNB needle designs. After a sample has been obtained, the ASGE suggests against the routine use of ROSE in patients undergoing an initial EUS-TA of a solid pancreatic mass. In patients with distal malignant biliary obstruction undergoing drainage with ERCP, the ASGE suggests using SEMS over plastic stents. In patients with proven malignancy undergoing SEMS placement, the ASGE suggests using cSEMS over uSEMS. If malignancy has not been histopathologically confirmed, the ASGE recommends against the use of uSEMS. Finally, in patients with unresectable pancreatic cancer and abdominal pain, the ASGE suggests the use of CPN as an adjunct for the treatment of abdominal pain. This document outlines the process, analyses, and decision approaches used to reach the final recommendations and represents the official ASGE recommendations on the above topics.
引用
- Machicado JD, Sheth SG, Chalhoub JM, et al. American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the diagnosis and management of solid pancreatic masses: summary and recommendations. Gastrointest Endosc. 2024. PMID: 39387777. doi:10.1016/j.gie.2024.06.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。